LEDA Pharma
Board
1 director, last change in 2020Director, permanent representative
appointed by deed of 01-07-2020
term without a fixed end
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 31-07-2026
Permanent representatives 1
Mandates through the years
4 names, the dashed line is todayDirector
Manager
Manager
Manager
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
-
- Director, appointed by deed of 01-07-2020, still in office
-
- Manager, appointed by deed of 21-06-2013, until 01-07-2020
-
- Manager, until 31-12-2012
- Manager, appointed by deed of 12-03-2018, until 01-07-2020
-
- Manager, appointed by deed of 20-02-2014, until 31-12-2017
- Manager, appointed by deed of 20-02-2014, no longer listed in the 2025 annual accounts
Control
Parent
Equity €428,624
Profit €115,380 in 2025 (profit €96,648 in 2024)
Checked score
100%
This company
LEDA Pharma
Equity -€51,021
Profit €6,990 in 2025
Further up the chain consolidates
Capital
- Contribution
- €6,200
- Source
- deed of 01-07-2020
Owners through the years
as the annual accounts name themOwners as a list
-
- 2024 to 2025: 100%
Source: parent in its own accounts, lists of holdings in the owners' accounts
Articles of association
deed of 01-07-2020 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Monday of June at 20:30
Shareholders
2 ownersOwners 2
- parentEquity €428,624 Profit of €115,380 in 2025 (profit of €96,648 in 2024) Checked scoreSourceaccounts 2025100%
- consolidating parentEquity €1.5m Profit of €90,551 in 2025 (profit of €163,035 in 2024) Checked scoreconsolidates